Skip to content
RYM

RYTHM, Inc.

RYTHM, Inc. Q4 FY2021 earnings call

March 23, 2022 · fiscal period ended 2021-12

EPS · actual vs est

$-869.57 / $-869.57Inline +0.0%

Revenue · actual vs est

$25.3M / $28.1MMiss -10.1%
Ask about this call

Summary

Generated 2022-03-23

Management highlights

  • In 2021, Agrify drove explosive year-over-year growth, with annual revenue growing from $12.1 million in 2020 to $59.9 million in 2021. Q4 2021 revenue was $25.3 million, a 481% increase year-over-year.
  • Generated over $377 million in new bookings in 2021, a 919% increase from 2020, and has a qualified pipeline of over $570 million.
  • The TTK program forges long-term partnerships with customers, addressing industry pain points, and expects to start high-margin recurring SaaS and production fees in Q3 2022.
  • The extraction division expanded by acquiring 4 leading brands to become a leader in cannabis extraction, with expectations of accretive revenue in 2022.
View in transcript ↓

Segment performance

In the fourth quarter of 2021, revenue was $25.3 million, a 481% year-over-year increase compared to $4.4 million in Q4 2020. For the full year 2021, revenue totaled $59.9 million, up 395% year-over-year from $12.1 million in 2020. The Total Turn-Key Solutions (TTK) program has secured 6 customers and has 3,729 Vertical Farming Units (VFUs) under contract, with expectations to generate $76 million of high-margin recurring revenue annually once all VFUs are commissioned. The extraction division, having acquired 4 top brands, expects to be accretive in 2022 with $62 million to $65 million in annual revenue and a profit margin of 30% or greater.

View in transcript ↓

Guidance

  • Q1 2022 revenue is expected to be $25.5 million, a ~264% increase from Q1 2021.
  • Full year 2022 revenue is expected to be $140 million to $142 million, a ~134% increase from 2021.
  • Second half of 2022 is anticipated to have a revenue mix with more high-margin extraction, SaaS, and production success fees.
View in transcript ↓

Risks

  • Shipments of VFUs in Illinois delayed due to social equity legal lawsuits.
  • Massachusetts regulator's slow approval process could impact Bud & Mary's completion and revenue timing.
  • Fluctuations in cannabis market demand and regulatory changes could affect business performance.
View in transcript ↓

Q&A highlights

Q: Aaron Grey asked about the 1Q revenue guide and seasonality.

A: There is slight seasonality in the extraction side, but large VFU bookings in Illinois were delayed by legal issues, with business expected to pick up in Q2.

Q: Eric Des Lauriers inquired about Bud & Mary's and recurring revenue.

A: Recurring revenue in Q3 is not from Bud & Mary's but from legacy customers, and Bud & Mary's is on schedule for Q4 completion with production in Q1 2023.

Q: Scott Fortune asked about VFUs and pipeline.

A: There are 3,729 VFUs under contract, with ~400 from legacy customers and others from Bud & Mary's and other programs.

Q: Anthony Vendetti asked about Bud N' Mary's Phase 2 and TTK recurring revenue.

A: There's an LOI with Frozen 4 for Phase 2 expansion including extraction, and TTK recurring revenues are expected to start in Q3 2022.

Q: Gerald Pascarelli asked about gross margin and capital allocation.

A: Q4 gross margin was high due to extraction equipment sales and old VFU sales, and capital allocation is focused on TTK projects with no immediate M&A in extraction.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$-869.57$-869.57+0.0%
Revenue$25.3M$28.1M-10.1%

Transcript

March 23, 2022

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.